Yahoo Web Search

  1. Ads
    related to fda
  1. Ardelyx is a biopharma company developing drugs for cardiorenal diseases. The Fremont, California-based company was launched in 2007 and does not have a commercial product on the market. The company's revenues so far have mostly come from licensing.

  2. Is it safe to vape?

    Quartz via Yahoo FinanceSep 09 20:20 PM

    In April of this year, the US Food and Drug Administration (FDA) began looking at the links between vaping and seizures after at least 35 reports surfaced.

  3. To ensure safe use by consumers, it's important that companies who sell products adhere to standards set forth by the FD&C Act, including product labeling and quality," said Acting FDA ...

  4. Here's Why Sarepta Therapeutics Dropped 39.4% in August

    Motley Fool via Yahoo FinanceSep 09 17:14 PM

    Food and Drug Administration (FDA) regarding two important drug candidates aimed at treating Duchenne muscular dystrophy (DMD). First, an FDA database tracking serious side effects ...

  5. The actively traded, small-cap biotech said after the close Tuesday that the FDA granted Orphan Drug Designation to Nerlynx for the treatment of breast cancer patients with brain metastases ...

  6. SILVER SPRING, Md., Sept. 11, 2019 /PRNewswire/ -- Today, the Trump Administration announced that as part of its ongoing work to tackle the epidemic of youth e-cigarette use, the FDA ...

  7. ACADIA Surges on Early Success of Nuplazid Dementia Study

    Zacks via Yahoo FinanceSep 10 15:41 PM

    Encouraging data from the study increases the probability of FDA approval for Nuplazid for a second indication, dementia-related psychosis, which led to a 63.2% rally in ACADIA’s shares ...

  8. Is Acadia Pharmaceuticals a Good Biotech Stock to Buy Now?

    Motley Fool via Yahoo FinanceSep 10 12:39 PM

    From the day the FDA gave Nuplazid a green light to treat Parkinson's disease-associated psychosis in 2016 until the day before Acadia announced success with dementia-driven psychosis ...

  9. Novartis CEO promises to speed data integrity disclosures

    Reuters via Yahoo FinanceSep 09 12:26 PM

    While the FDA has concluded Zolgensma is safe and effective and should remain on the market, the U.S. drug watchdog raised questions about the timing of Novartis's disclosure.

  10. This action should have been the role of the FDA, but it has egregiously failed its mission to protect our kids. The job of the FDA is to regulate, not negotiate, with an industry ...

  1. Ads
    related to fda